What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis).

Efficacy of Factor Xa Inhibitors Versus Placebo in Thromboprophylaxis for Cancer-Associated Thromboembolism: A Systematic Review and Meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

Systematic review identifies Factor Xa inhibitors' role in VTE prevention for cancer patients, suggesting safety concerns may limit use.

Factor Xa inhibitors show a non-significant reduction in VTE incidence amongst cancer patients, indicating potential efficacy.
Pooled results from six RCTs involving 2330 participants showed an increased major bleeding risk with RR = 1.90, raising safety concerns.
This systematic review and meta-analysis adhered to PRISMA guidelines, ensuring a comprehensive literature assessment.
Findings suggest further large-scale trials are needed to clarify the safety and efficacy of Factor Xa inhibitors in this population.

Kamil et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark